Bee Venom Phospholipase A(2): Yesterday’s Enemy Becomes Today’s Friend

Bee venom therapy has been used to treat immune-related diseases such as arthritis for a long time. Recently, it has revealed that group III secretory phospholipase A(2) from bee venom (bee venom group III sPLA(2)) has in vitro and in vivo immunomodulatory effects. A growing number of reports have d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Gihyun, Bae, Hyunsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773801/
https://www.ncbi.nlm.nih.gov/pubmed/26907347
http://dx.doi.org/10.3390/toxins8020048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773801/
https://www.ncbi.nlm.nih.gov/pubmed/26907347
http://dx.doi.org/10.3390/toxins8020048

Ejemplares similares